financetom
Business
financetom
/
Business
/
Intapp Fiscal Q4 Non-GAAP EPS, Revenue Increase; Shares Rise After Hours
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Intapp Fiscal Q4 Non-GAAP EPS, Revenue Increase; Shares Rise After Hours
Aug 12, 2025 1:54 PM

04:37 PM EDT, 08/12/2025 (MT Newswires) -- Intapp ( INTA ) reported fiscal Q4 non-GAAP earnings Tuesday of $0.27 per diluted share, up from $0.15 a year earlier.

Analysts polled by FactSet expected $0.23 per share.

Revenue for the quarter ended June 30 was $135 million, up from $114.4 million a year earlier.

Analysts surveyed by FactSet expected $132.1 million.

The company expects fiscal Q1 non-GAAP diluted EPS of $0.18 to $0.20 and revenue of $134.8 million to $135.8 million.

Analysts polled by FactSet expect $0.23 and $134 million.

The company expects fiscal 2026 non-GAAP diluted EPS of $1.09 to $1.13 and revenue of $566.7 million to $570.7 million.

Analysts surveyed by FactSet expect $1.04 and $562.6 million.

The company's shares were up nearly 22% in after-hours trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Looking At Caterpillar's Recent Unusual Options Activity
Looking At Caterpillar's Recent Unusual Options Activity
Jan 8, 2025
Financial giants have made a conspicuous bullish move on Caterpillar ( CAT ). Our analysis of options history for Caterpillar ( CAT ) revealed 23 unusual trades. Delving into the details, we found 39% of traders were bullish, while 34% showed bearish tendencies. Out of all the trades we spotted, 8 were puts, with a value of $611,787, and 15...
Catalyst Pharmaceuticals Reaches Settlement With Teva in Firdapse Patent Litigation
Catalyst Pharmaceuticals Reaches Settlement With Teva in Firdapse Patent Litigation
Jan 8, 2025
01:15 PM EST, 01/08/2025 (MT Newswires) -- Catalyst Pharmaceuticals ( CPRX ) and its licensor SERB have reached a settlement agreement with Teva Pharmaceuticals USA and Teva Pharmaceuticals (TEVA) to resolve the Firdapse patent litigation, Catalyst said Wednesday. Under the terms of the settlement, Teva will not market its generic version of Firdapse in the US any earlier than Feb....
Update: Market Chatter: JPMorgan Files Additional Lawsuits Over Greek Fintech Investment
Update: Market Chatter: JPMorgan Files Additional Lawsuits Over Greek Fintech Investment
Jan 8, 2025
01:25 PM EST, 01/08/2025 (MT Newswires) -- (Updates with Viva CEO's statement in sixth and seventh paragraphs.) JPMorgan ( JPM ) filed two additional lawsuits in connection with its investment in Greek fintech Viva Wallet, Bloomberg reported Wednesday. A lawsuit filed in Greece, which asserts a claim of 916 million euros ($944.9 million), alleged that Viva Chief Executive Officer Haris...
What's Going On With Currenc Group Shares Wednesday?
What's Going On With Currenc Group Shares Wednesday?
Jan 8, 2025
Currenc Group Inc. ( CURR ) shares are trading higher on Wednesday after the company announced the launch of its SEAMLESS Artificial Intelligence (AI) Call Center. The Details: The AI call center is designed to increase efficiency for financial institutions, telecommunications companies, government agencies, cryptocurrency exchanges and other types of institutions by providing them with three distinct software products. Currenc...
Copyright 2023-2026 - www.financetom.com All Rights Reserved